Immunotherapy Is a Good Standard Option for Patients With Malignant Pleural Mesothelioma, Despite the Real-World Results From Australia. Smesseim I, Baas P. J Thorac Oncol 2024;19:547-550.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Smesseim I, Baas P. Immunotherapy Is a Good Standard Option for Patients With Malignant Pleural Mesothelioma, Despite the Real-World Results From Australia. J Thorac Oncol 2024;19:547-550.
PMID: 38582547